Rapid diagnostic HCV antibody assays.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Antiviral Therapy

• Publication date

  2012-12-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.3851/IMP2470PMID 23322678PMCID PMC5791540
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis C core Ag and its clinical applicability: Potential advantages and disadvantages for diagnosis and follow‐up?

  2012cited by this paper
• Field-based performance of three pre-market rapid hepatitis C virus antibody assays in STAHR (Study to Assess Hepatitis C Risk) among young adults who inject drugs in San Diego, CA.

  2012cited by this paper
• Summary of notifiable diseases: United States, 2009.

  2011cited by this paper
• HCV screening practices and prevalence in an MCO, 2000-2007.

  2011cited by this paper
• Testing and Linkage to Care Outcomes for a Clinician-Initiated Rapid HIV Testing Program in an Urban Emergency Department

  2011cited by this paper
• Female Sex and IL28B, a Synergism for Spontaneous Viral Clearance in Hepatitis C Virus (HCV) Seroconverters from a Community-Based Cohort

  2011cited by this paper
• Evaluation of three rapid screening assays for detection of antibodies to hepatitis C virus.

  2011cited by this paper
• Hepatitis C testing practices and prevalence in a high‐risk urban ambulatory care setting

  2011cited by this paper
• Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites.

  2011cited by this paper
• Public health implications of rapid hepatitis C screening with an oral swab for community-based organizations serving high-risk populations.

  2011cited by this paper
• Evaluation of a new, rapid test for detecting HCV infection, suitable for use with blood or oral fluid.

  2011cited by this paper
• HCV‐specific T cells in HCV/HIV co‐infection show elevated frequencies of dual Tim‐3/PD‐1 expression that correlate with liver disease progression

  2010cited by this paper
• Evaluation of a rapid, point-of-care test device for the diagnosis of hepatitis C infection.

  2010cited by this paper
• Trends in Hepatitis C Virus Infection Among Patients in the HIV Outpatient Study, 1996–2007

  2010cited by this paper
• Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place.

  2008cited by this paper
• HIV Prevalence Rates among Injection Drug Users in 96 Large US Metropolitan Areas, 1992–2002

  2008cited by this paper
• Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

  2008cited by this paper
• The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002

  2006cited by this paper
• Injection drug users: the overlooked core of the hepatitis C epidemic.

  2006cited by this paper
• Relative Efficacy of Prevention Counseling With Rapid and Standard HIV Testing: A Randomized, Controlled Trial (RESPECT-2)

  2005cited by this paper
• The role of rapid vs conventional human immunodeficiency virus testing for inpatients: effects on quality of care.

  2005cited by this paper
• Choosing HIV Counseling and Testing Strategies for Outreach Settings: A Randomized Trial

  2005cited by this paper
• Delivering care to injection drug users coinfected with HIV and hepatitis C virus.

  2005cited by this paper
• Outcomes of Offering Rapid Point-of-Care HIV Testing in A Sexually Transmitted Disease Clinic

  2005cited by this paper
• Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

  2003cited by this paper
• Guidelines for Preventing Opportunistic Infections among HIV-Infected Persons2002: Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America*

  2002cited by this paper
• Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment.

  2002cited by this paper
• Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay

  2002cited by this paper
• Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

  2002cited by this paper
• Rapid hiv testing in urban outreach: a strategy for improving posttest counseling rates.

  2001cited by this paper
• Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco

  2001cited by this paper
• Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

  2000cited by this paper
• Predictors of failure to return for HIV test result and counseling by test site type.

  1999cited by this paper
• Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.

  1998cited by this paper
• Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

  1998cited by this paper
• Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease

  1998cited by this paper

• Current and Future Diagnostics for Hepatitis C Virus Infection

  2025cites this paper
• Characteristics and antiviral treatment eligibility of patients diagnosed with hepatitis B at a teaching hospital in Ghana: Implications for prevention and management

  2024cites this paper
• Progress in diagnosis and treatment of hepatitis C

  2024cites this paper
• Adenoviruses vectored hepatitis C virus vaccine cocktails induce broadly specific immune responses against multi-genotypic HCV in mice.

  2023cites this paper
• Hepatitis C outreach project and cross-sectional epidemiology in high-risk populations in Trondheim, Norway

  2021cites this paper
• Hepatitis C Virus

  2020cites this paper
• Pharmacy-Based Infectious Disease Management Programs Incorporating CLIA-Waived Point-of-Care Tests

  2020cites this paper
• Developments in the HCV Screening Technologies Based on the Detection of Antigens and Antibodies

  2019cites this paper
• IMMUNOCHROMATOGRAPHY AND CHEMILUMINESCENCE FOR DETECTION OF ANTI HCV ANTIBODIES IN DIAGNOSIS OF HEPATITIS C INFECTION AMONG HEALTHY BLOOD DONORS

  2018cites this paper
• The evaluation of point of care testing and dried blood spots to assess diagnostic accuracy of HCV infection as part of Sero-Molecular surveillance in people most-at-risk for hepatitis C virus

  2018cites this paper
• Hepatitis virus (HCV) diagnosis and access to treatment in a UK cohort

  2018cites this paper
• Development of a Rapid Automated Fluorescent Lateral Flow Immunoassay to Detect Hepatitis B Surface Antigen (HBsAg), Antibody to HBsAg, and Antibody to Hepatitis C

  2018cites this paper
• Hepatitis C Virus (HCV) diagnosis, epidemiology and access to treatment in a UK cohort

  2017cites this paper
• Field evaluation of the performance of HCV Serological Rapid Diagnostic Tests among HCV/HIV co-infected patients

  2017cites this paper
• Potential for Pharmacy–Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases

  2017cites this paper
• A pilot study of rapid hepatitis C virus testing in the Rhode Island Department of Corrections.

  2016cites this paper
• Diagnostic Accuracy of Point-of-Care Tests for Hepatitis C Virus Infection: A Systematic Review and Meta-Analysis

  2015influential citation
• A potential loophole in early diagnosis of the hepatitis B and hepatitis C

  2015cites this paper
• Changing strategies for hepatitis C testing.

  2012cites this paper